Endoscopic Evaluation of Swallowing in Patient with Tetanus Followed by Myasthenia Gravis as its Complication
DOI:
https://doi.org/10.18196/mmjkk.v22i2.12221Keywords:
dysphagia, FEES, myasthenia gravis, tetanusAbstract
Flexible Endoscopic Evaluation of Swallowing (FEES) provides direct visualization of the pharynx and larynx immediately before and after a swallow in a patient with dysphagia. Dysphagia is the difficulty in swallowing solid or liquid food. It is a symptom of an underlying disease like tetanus and myasthenia gravis. This case report showed the important role of FEES in patients with dysphagia due to tetanus followed by myasthenia gravis as its complication. A 58-year-old man had complaints of severe difficulty in swallowing followed by complaints of fever and whole body seizures, which supported the diagnosis of tetanus. In the course of the disease, symptoms and the results of supporting examinations indicated the presence of myasthenia gravis. Comprehensive management had done with colleagues in internal medicine, neurology and medical rehabilitation. That condition improved and the complaints disappeared after one month. It can be concluded that FEES played an important role in diagnosing dysphagia. It could identify the modification of food consistencies and therapeutic maneuvers to prevent an aspiration for a patient with dysphagia as the early symptom of tetanus which caused neurotransmitter damage that broke muscle nerve junctions. It is also one of the predisposing factors for autoimmune conditions in myasthenia gravis. Correct diagnosis and comprehensive management give a better improvement for the disease.
References
Ambika RS, Datta B, Manjula BV, Warawantkar UV, Thomas AM. Fiberoptic Endoscopic Evaluation of Swallow (FEES) in Intensive Care Unit Patients Post Extubation. Indian J. Otolaryngol Head Neck Surg. 2019; 71(2): 266-270. https://doi.org/10.1007/s12070-018-1275-x
Kuhn M, Belafsky P. Functional assessment of swallowing. In: Johnson J, Rosen C, eds. Bailey’s head and neck surgery - otolaryngology. Fifth. Philadelphia: Lippincott Williams and Wilkins; 2014:825–837.
Mezoff EA. Dysphagia. Pediatr Rev. 2012;33(11):518–520. https://doi.org/10.1542/pir.33.11.518
Smith L. Upper digestive tract anatomy and physiology. In: Johnson J, Rose C, eds. Bailey’s head and neck surgery otolaryngology. Fifth. Philadelphia: Lippincott Williams and Wilkins; 2014:817–824.
Fusetti S, Ghirotto C, Ferronato G. A case of cephalic tetanus in a developed country. Int J Immunopathol Pharmacol. 2013;26(1):273–277. https://doi.org/10.1177/039463201302600131
Shin MC, Nonaka K, Wakita M, et al. Effects of tetanus toxin on spontaneous and evoked transmitter release at inhibitory and excitatory synapses in the rat SDCN neurons. Toxicon. 2012;59(3):385–392. https://doi.org/10.1016/j.toxicon.2011.12.009
J CH, D PR. A review : Myasthenia gravis and related disorders: Pathology and molecular pathogenesis. Biochim Biophys Acta. 2015;1852:651–657. https://doi.org/10.1016/j.bbadis.2014.11.022
Hassel B. Tetanus: Pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms. Toxins (Basel). 2013;5(1):73–83. https://doi.org/10.3390/toxins5010073
Kolegium ilmu kesehatan telinga hidung tenggorok bedah kepala dan leher. Disfagia Orofaringeal. Modul Perhati-KL2015.
Setiyohadi BSA, Alwi I, Simadibrata M, Setiati S. Tetanus. Dalam: Ed 4th . Jakarta : FK Universitas Indonesia2008.p:1799-807. In: Ilmu Penyakit Dalam. 4th ed. Jakarta: FK Universitas Indonesia; 2008:1799–1807.
Julianti E, Madiadipoera T, Anggraeni R, Purwanto B, Ratunanda S. Peningkatan Functional Oral Intake Scale dan 1Kualitas Hidup Pada Miastenia Gravis Pasca Rehabilitasi Menelan. ORLI. 2016;46. https://doi.org/10.32637/orli.v46i1.150
Chilukuri P, Odufalu F, Hachem C. Dysphagia. Mo Med. 2018;115(3):206 – 210.
Dong M, Masuyer G, Stenmark P. Botulinum and tetanus neurotoxins. Annu Rev Biochem. 2019;88:811–837. https://doi.org/10.1146/annurev-biochem-013118-111654
Hinfey PB, co autor Ripper J. Tetanus. Available from: http://emedicine.medscape.com/article/229594-overview. Update on 2016 June 16th.
Melzer N, Ruck T, Fuhr P, et al. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. J Neurol. 2016;263(8):1473–1494. https://doi.org/10.1007/s00415-016-8045-z
Jayam Trouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J. Myasthenia gravis: A review. Autoimmune Dis. 2012;1(1). https://doi.org/10.1155/2012/874680
Goldenberg, William. Myasthenia Gravis. 20 Januari 2012. Available from http://emedicine.medscape.com/article/1171206-overview, 09 December 2014.
Sanders DB, Wolfe GI, Narayanaswarni P. A review : Developing treatment guidelines for myasthenia gravis. Ann N Y Acad Sci. 2018:95–110. https://doi.org/10.1111/nyas.13537
Narayanaswami P, Sanders DB, Wolfe G, et al. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology. 2021;96(3):114–122. https://doi.org/10.1212/WNL.0000000000011124
Farmakidis C, Pasnoor M, Dimachkie MM, Barohn RJ. Treatment of Myasthenia Gravis. Neurol Clin. 2018;36(2):311–337. https://doi.org/10.1016/j.ncl.2018.01.011
Downloads
Published
Issue
Section
License
Copyright
Authors retain copyright and grant Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
License
Articles published in the Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) are licensed under an Attribution 4.0 International (CC BY 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
